Johnson & Johnson’s Janssen vaccine has been administered at a farlower rate than either the Moderna or Pfizer vaccines in Arizona.
By Stephanie Innes, Alison Steinbach | Arizona Republic
Certain hard-to-reach populations in Arizona could be missing out on getting protection from COVID-19 during a pause on the Johnson & Johnson COVID-19 vaccine.
Johnson & Johnson’s Janssen vaccine has been administered at a farlower rate than either the Moderna or Pfizer vaccines in Arizona. But it still is an important vaccine for some groups of people, including people with transportation and housing issues, and people with inflexible job obligations.
The Janssen vaccine has several advantages that the other two vaccines do not: It requires only refrigeration and not a deep freezer for storage; it’s a single dose instead of two; it requires fewer medical staff and other resources for clinics administering the vaccine; and because it’s just one dose, those who receive the vaccine are considered fully vaccinated after two weeks rather than five or six.
In Arizona, the vaccine has been popular at community health clinics and at targeted events in underserved communities or for essential workers. Some people have sought out the vaccine because of the convenience of only having to get one shot.
